China (Mainland)
Diamondsupplier 
98% up Sugammadex Sodium powder CAS NO.343306-79-6
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,
- Product Details
Keywords
- Sugammadex Sodium
- Sugammadex
- Sugammadex Sodium powder
Quick Details
- ProName: 98% up Sugammadex Sodium powder
- CasNo: 343306-79-6
- Molecular Formula: C72H104Na8O48S8
- Appearance: White powder
- Application: control the degree of muscle relaxatio...
- DeliveryTime: in 7 days after your payment
- PackAge: 1kg/bag ;25kg/drum
- Port: Shanghai/Beijing/Hangzhou
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 98% up
- Storage: Normal
- Transportation: Normal
- LimitNum: 1 Kilogram
Superiority
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Details
- Product Details
|
Product Information |
|
Product name |
Sugammadex Sodium |
|
CAS No. |
343306-79-6 |
|
Molecular Formula |
C72H104Na8O48S8 |
|
Molecular Weight |
2177.97 |
|
Quality Standard |
98% up |
|
Appearance |
White powder |
|
Usage |
Sugammadex Sodium is the first and only selective relaxation binder, a major advancement in the field of muscle relaxants in the past 20 years. It allows the anesthesiologist to control the degree of muscle relaxation during the entire operation and increase the number of The quality of millions of operations represents the first major advancement in 20 years, making it possible to reverse surgical anesthesia.
Advantage of Sugammadex Sodium
1. The effect is remarkable and the effect is fast. The effect of antagonizing moderate and deep muscle relaxation can be quickly reversed, and the effect is complete. The average time from deep muscle relaxation to functional recovery is only 2-3 minutes.
2. Good tolerance and low incidence of adverse reactions. For some special populations, such as obese patients, elderly patients, children aged 2-17, patients with heart disease, patients with lung disease, and those with mild to moderate liver and kidney damage, no dose adjustment is required.
